Glossary

Placebo

02.27.12

A dosage form not containing the active drug given, for example, in clinical trials to the control group to differentiate the drug effect from the psychological effect of treatment.

Related Drug Discovery and Development:

  • Clinical Trials

    Clinical Trials

    Carefully designed investigations of the effects of investigational new drugs, medical treatments, or devices on a group of patients. There are typically three phases of clinical trials prior to the filing of an NDA, sometimes followed by ongoing, po…
    02.27.12

  • Clinical Trials | R&D

    Contract Manufacturing Organization (CMO)

    A company that offers manufacturing services, with volume capabilities ranging from small amounts for preclinical R&D to larger volumes necessary for clinical trials purposes and commercialization.…
    02.27.12

  • Clinical Trials

    Endpoint

    In clinical trials, a parameter used to compare the results in different arms of the trial. Endpoints may be directly related to the condition (such as progression of the disease) or may be measurements of surrogate markers.…
    02.27.12

  • Clinical Trials

    Investigational New Drug Application (IND)

    An application to the FDA to begin clinical trials of a new drug or biologic on humans. The IND gives the plan for the study and contains formulation, manufacturing and animal test result information.…
    02.27.12

  • Clinical Trials

    Lead Compound

    A peptide or small molecule that can bind to a target and bring about a therapeutic effect. A successful lead compound will become a drug candidate for clinical trials. See Derivative.…
    02.27.12

  • Clinical Trials

    New Drug Application (NDA)

    An application to FDA for a license to market a new drug in the U.S. Sponsor companies submit NDAs after completing clinical trials on a new drug.…
    02.27.12

  • Clinical Trials

    Data and Safety Monitoring Board (DSMB)

    A group of researchers who periodically review data from blinded, placebo-controlled clinical trials. A DSMB board can stop a trial if toxicities are found or if the treatment is proved beneficial.…
    02.27.12

  • Clinical Trials

    Electronic Data Capture (EDC)

    Collection of data in an electronic format, typically used in reference to data obtained from clinical trials.…
    02.27.12